Devonian Health Group (TSXV:GSD) EBIT per Share : C$0.01 (TTM As of Jan. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group EBIT per Share?

Devonian Health Group's EBIT per Share for the three months ended in Jan. 2025 was C$0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2025 was C$0.01.

During the past 3 years, the average EBIT per Share Growth Rate was 38.70% per year. During the past 5 years, the average EBIT per Share Growth Rate was 29.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Devonian Health Group's EBIT per Share or its related term are showing as below:

TSXV:GSD' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 4.1 Med: 17.6 Max: 38.7
Current: 38.7

During the past 11 years, the highest 3-Year average EBIT per Share Growth Rate of Devonian Health Group was 38.70% per year. The lowest was 4.10% per year. And the median was 17.60% per year.

TSXV:GSD's 3-Year EBIT Growth Rate is ranked better than
84.35% of 1233 companies
in the Biotechnology industry
Industry Median: 8 vs TSXV:GSD: 38.70

Devonian Health Group's EBIT for the three months ended in Jan. 2025 was C$0.24 Mil.

Devonian Health Group EBIT per Share Historical Data

The historical data trend for Devonian Health Group's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Devonian Health Group EBIT per Share Chart

Devonian Health Group Annual Data

Trend

Jun15

Jun16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Jul24

EBIT per Share

Get a 7-Day Free Trial

-0.05

-0.03

-0.02

-0.03

-0.01

Devonian Health Group Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
EBIT per Share	Get a 7-Day Free Trial															-0.01	-	0.01	-	-

Devonian Health Group EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Devonian Health Group's EBIT per Share for the fiscal year that ended in Jul. 2024 is calculated as

	EBIT per Share		(A: Jul. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.845	/	147.110
=	-0.01

Devonian Health Group's EBIT per Share for the quarter that ended in Jan. 2025 is calculated as

	EBIT per Share		(Q: Jan. 2025 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.243	/	148.223
=	0.00

EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.01

Devonian Health Group (TSXV:GSD) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Devonian Health Group EBIT per Share Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Devonian Health Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

DVHGF:USA

Address

360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1

Website

https://www.groupedevonian.com

Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines